Progress toward a new flu treatment, thanks to a small tweak

This year’s aggressive flu season reminds everyone that although the flu vaccine can reduce the number of people who contract the virus, it is still not 100 percent effective. A tweak to a small-molecule drug shows promise for future production of new antiviral therapies that could help patients, regardless of the strain with which they are infected.

For more ground-breaking science, please check out ACS in the News: https://www.acs.org/content/acs/en/pr...

Subscribe! http://bit.ly/AmerChemSOc
Facebook! Facebook: AmericanChem..
Twitter! Twitter: ACSpressroom

You might also like:

Press Conferences from #ACSsanFran:
No more ‘superbugs’? Maple syrup extr...

Press Conferences from #Philadelphia:
Paper - based device spots falsified ...

Press Conferences from #SanDiego:
Getting closer to using beer hops to ...

Press Conferences from #Denver:
Inaugural issue of ACS Central Scienc...

Music: From Audioblocks

Produced by the American Chemical Society, the world’s largest scientific society. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences.

Join the American Chemical Society! https://bit.ly/Join_ACS

• #science_technology
• #acs_nola_press_conferences
• #255th_national_meeting_exposition_in_new_orleans
• #ground_breaking_research
• #acs_publications
• #american_chemical_society
• #university_of_california
• #san_diego
• #seth_cohen
• #a_new_flu_treatment
• #flu_season
• #vaccine
• #contract_the_virus
• #small_molecule_drug
• #new_antiviral_therapies
• #future_production
• #infection